IN184589B
(cs)
*
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
WO2001037804A2
(en)
*
|
1999-11-22 |
2001-05-31 |
Universal Preservation Technologies, Inc. |
Preservation and formulation of bioactive materials
|
US7456009B2
(en)
*
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
AU4346101A
(en)
*
|
2000-03-07 |
2001-09-17 |
Merck & Co., Inc. |
Adenovirus formulations
|
US7153472B1
(en)
|
2000-11-22 |
2006-12-26 |
Quadrant Drug Delivery Limited |
Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
|
US6827250B2
(en)
*
|
2001-06-28 |
2004-12-07 |
Microchips, Inc. |
Methods for hermetically sealing microchip reservoir devices
|
WO2003048665A1
(en)
|
2001-12-03 |
2003-06-12 |
Massachusetts Institute Of Technology |
Microscale lyophilization and drying methods for the stabilization of molecules
|
AU2003233396B2
(en)
*
|
2002-03-13 |
2007-05-24 |
Thomas Skold |
Water-based delivery systems
|
CN100594892C
(zh)
*
|
2002-08-16 |
2010-03-24 |
微芯片公司 |
使用电热消融的受控释放的装置和方法
|
WO2004022033A1
(en)
*
|
2002-09-04 |
2004-03-18 |
Microchips, Inc. |
Method and device for the controlled delivery of parathyroid hormone
|
BR0314751A
(pt)
*
|
2002-09-27 |
2005-07-26 |
Powderject Res Ltd |
Partìculas adequadas para suprimento a partir de um dispositivo de suprimento, receptáculo de dosagem para um dispositivo de suprimento, dispositivo de suprimento mediado por partìcula, processo para a preparação de partìculas adequadas para suprimento a partir de um dispositivo de suprimento, e, métodos de imunização por ácido nucleico e de terapia genética
|
WO2004033034A1
(en)
|
2002-10-04 |
2004-04-22 |
Microchips, Inc. |
Medical device for neural stimulation and controlled drug delivery
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
DK2526996T3
(da)
|
2002-12-20 |
2019-12-02 |
Xeris Pharmaceuticals Inc |
Formulering til intrakutan injektion
|
US8084424B2
(en)
*
|
2003-04-09 |
2011-12-27 |
University Of Utah Research Foundation |
Compositions and methods related to erythropoietin
|
JP4734236B2
(ja)
*
|
2003-04-25 |
2011-07-27 |
ボストン サイエンティフィック サイムド,インコーポレイテッド |
固形型の薬物の貯蔵及び制御された放出のための装置及びその製造方法
|
US7892205B2
(en)
|
2003-06-06 |
2011-02-22 |
Boston Scientific Scimed, Inc. |
Device and method for delivering micronized therapeutic agents in the body
|
WO2005041767A2
(en)
*
|
2003-11-03 |
2005-05-12 |
Microchips, Inc. |
Medical device for sensing glucose
|
JP2008501037A
(ja)
*
|
2004-06-01 |
2008-01-17 |
マイクロチップス・インコーポレーテッド |
医療移植片への/医療移植片からの薬物または分析物の輸送の測定および輸送の増強のためのデバイスおよび方法
|
US7537590B2
(en)
*
|
2004-07-30 |
2009-05-26 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
US7772182B2
(en)
*
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
US20060029551A1
(en)
*
|
2004-08-05 |
2006-02-09 |
Kui Liu |
Stable particle formulations of erythropoietin receptor agonists
|
AU2005279729B2
(en)
*
|
2004-09-01 |
2010-12-02 |
Microchips, Inc. |
Multi-cap reservoir devices for controlled release or exposure of reservoir contents
|
MX2007002925A
(es)
*
|
2004-09-10 |
2007-08-14 |
Becton Dickinson Co |
Dispositivo de infusion reconstituyente.
|
US7488316B2
(en)
|
2005-01-25 |
2009-02-10 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
CN101511170B
(zh)
*
|
2005-12-22 |
2014-03-26 |
奥克伍德药业有限公司 |
可升华持续释放传递系统和其制造方法
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
LT2134353T
(lt)
*
|
2007-03-30 |
2017-03-27 |
Xisle Pharma Ventures Trust |
Dvifazė lipidų vezikulių kompozicija ir gimdos kaklelio displazijos gydymo būdas, skiriant intravaginaliai
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
HUE043228T2
(hu)
|
2007-06-22 |
2019-08-28 |
Univ Texas |
Stabil szubmikron peptid vagy protein részecskék képzése vékonyfilm fagyasztással
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
CA2743789C
(en)
|
2008-11-16 |
2017-10-31 |
Board Of Regents, The Univesity Of Texas System |
Low viscosity highly concentrated suspensions
|
EP2398466B1
(en)
*
|
2008-11-24 |
2021-02-17 |
Massachusetts Institute of Technology |
Methods and compositions for localized nanoparticle delivery to a tumor
|
CN107638562B
(zh)
|
2009-09-28 |
2022-12-02 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
US9072668B2
(en)
|
2010-03-09 |
2015-07-07 |
Janssen Biotech, Inc. |
Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
|
CN103096934A
(zh)
*
|
2010-03-09 |
2013-05-08 |
詹森生物科技公司 |
非水性高浓度低粘度混悬剂
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
CN102869345B
(zh)
|
2010-03-17 |
2015-02-11 |
诺瓦利克有限责任公司 |
用于治疗眼内压增高的药物组合物
|
WO2012012460A1
(en)
|
2010-07-19 |
2012-01-26 |
Xeris Pharmaceuticals, Inc. |
Stable glucagon formulations for the treatment of hypoglycemia
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
CN103442695B
(zh)
|
2011-03-10 |
2016-05-04 |
Xeris药物公司 |
肠胃外注射用肽药物的稳定制剂
|
PL3192501T3
(pl)
|
2011-05-25 |
2020-11-02 |
Novaliq Gmbh |
Kompozycja farmaceutyczna do miejscowego stosowania oparta na semifluorowanych alkanach
|
CA2834862C
(en)
|
2011-05-25 |
2019-12-17 |
Novaliq Gmbh |
Pharmaceutical composition for administration to nails
|
CA2853942C
(en)
|
2011-10-31 |
2020-08-25 |
Xeris Pharmaceuticals, Inc. |
Formulations for the treatment of diabetes
|
KR101989648B1
(ko)
|
2012-01-23 |
2019-06-14 |
노바리크 게엠베하 |
부분불소화 알칸에 기초한 안정화된 단백질 조성물
|
US9125805B2
(en)
|
2012-06-27 |
2015-09-08 |
Xeris Pharmaceuticals, Inc. |
Stable formulations for parenteral injection of small molecule drugs
|
ES2965828T3
(es)
|
2012-09-12 |
2024-04-17 |
Novaliq Gmbh |
Composiciones de alcano semifluorado
|
CA2883002C
(en)
|
2012-09-12 |
2019-05-21 |
Novaliq Gmbh |
Compositions comprising mixtures of semifluorinated alkanes
|
ES2927844T3
(es)
|
2013-01-11 |
2022-11-11 |
Corsair Pharma Inc |
Profármacos de treprostinil
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
US9018162B2
(en)
|
2013-02-06 |
2015-04-28 |
Xeris Pharmaceuticals, Inc. |
Methods for rapidly treating severe hypoglycemia
|
EP2968498A4
(en)
*
|
2013-03-15 |
2016-09-07 |
Biogen Ma Inc |
PREPARATIONS CONTAINING FACTOR IX POLYPEPTIDE
|
US10273298B2
(en)
|
2013-07-23 |
2019-04-30 |
Novaliq Gmbh |
Stabilized antibody compositions
|
US8986732B2
(en)
|
2013-08-12 |
2015-03-24 |
Helix Biopharma Corporation |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
US10159646B2
(en)
|
2013-08-12 |
2018-12-25 |
Altum-Avro Pharma Partnership |
Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
|
EP3043775B1
(en)
|
2013-09-11 |
2020-11-04 |
Eagle Biologics, Inc. |
Liquid protein formulations containing viscosity-lowering agents
|
CA3191031A1
(en)
|
2013-09-27 |
2015-04-02 |
Massachusetts Institute Of Technology |
Carrier-free biologically-active protein nanostructures
|
EP3123090A4
(en)
*
|
2014-03-24 |
2017-12-13 |
Bioverativ Therapeutics Inc. |
Lyophilized factor ix formulations
|
WO2016010538A1
(en)
|
2014-07-16 |
2016-01-21 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
AU2015300944B2
(en)
|
2014-08-06 |
2019-07-11 |
Xeris Pharmaceuticals, Inc. |
Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
KR102497368B1
(ko)
|
2014-10-01 |
2023-02-10 |
이글 바이올로직스 인코포레이티드 |
점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형
|
US10925639B2
(en)
|
2015-06-03 |
2021-02-23 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
US9649364B2
(en)
|
2015-09-25 |
2017-05-16 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic formulations in aprotic polar solvents
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
AU2016305087B2
(en)
|
2015-08-12 |
2022-01-20 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
US11590205B2
(en)
|
2015-09-25 |
2023-02-28 |
Xeris Pharmaceuticals, Inc. |
Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
|
CN110403923B
(zh)
|
2015-09-30 |
2021-09-21 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
EP3722274B1
(en)
|
2015-09-30 |
2023-06-07 |
Novaliq GmbH |
2-perfluorobutyl pentane for ophthalmic administration
|
BR112018073511A2
(pt)
|
2016-05-16 |
2019-03-26 |
Intarcia Therapeutics, Inc. |
polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
WO2017218533A1
(en)
|
2016-06-13 |
2017-12-21 |
Torque Therapeutics, Inc. |
Methods and compositions for promoting immune cell function
|
DK3442480T3
(da)
|
2016-06-23 |
2020-01-13 |
Novaliq Gmbh |
Fremgangsmåde til topisk indgivelse
|
ES2969758T3
(es)
|
2016-09-22 |
2024-05-22 |
Novaliq Gmbh |
Composiciones farmacéuticas para usar en la terapia de la blefaritis
|
CN109906085B
(zh)
|
2016-09-23 |
2024-03-08 |
诺瓦利克有限责任公司 |
含有环孢素的眼用组合物
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
AU2018253944B2
(en)
|
2017-04-21 |
2022-09-15 |
Dermaliq Therapeutics, Inc. |
Iodine compositions
|
EP3621601A1
(en)
|
2017-05-12 |
2020-03-18 |
Novaliq GmbH |
Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
|
CA3063324A1
(en)
|
2017-05-16 |
2018-11-22 |
Bhami's Research Laboratory, Pvt. Ltd. |
High concentration protein formulations with reduced viscosity
|
CN117085022A
(zh)
|
2017-06-02 |
2023-11-21 |
Xeris药物公司 |
抗沉淀的小分子药物制剂
|
CA3074826A1
(en)
|
2017-09-05 |
2019-03-14 |
Torque Therapeutics, Inc. |
Therapeutic protein compositions and methods of making and using the same
|
US11723861B2
(en)
|
2017-09-27 |
2023-08-15 |
Novaliq Gmbh |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
|
US11896559B2
(en)
|
2017-10-04 |
2024-02-13 |
Novaliq Gmbh |
Opthalmic compositions comprising F6H8
|
SG11202007858VA
(en)
|
2018-03-02 |
2020-09-29 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
WO2019217637A1
(en)
*
|
2018-05-09 |
2019-11-14 |
Biomatrica, Inc. |
Stabilization of proteins in biological samples
|
SG11202102820VA
(en)
|
2018-10-12 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
SG11202107901QA
(en)
|
2019-02-05 |
2021-08-30 |
Lindy Biosciences Inc |
Isolated cell culture components and methods for isolating the same from liquid cell culture medium
|
WO2021109979A1
(en)
|
2019-12-06 |
2021-06-10 |
Guangzhou Bioseal Biotech Co., Ltd. |
Flowable fibrinogen thrombin paste
|
WO2023044455A2
(en)
*
|
2021-09-16 |
2023-03-23 |
Team Medical Llc |
Rna stabilization
|